Rpn11 is responsible for deubiquitinylation of proteasomal substrates (Verma et al., 2002) Inhibition of Rpn11 has been reported to overcome bortezomib resistance and induce apoptosis in multiple myeloma cells (Song et al., 2017). The gene discussed is PSMD14; the disease is plasma cell myeloma.